Intravacc offers four complementary vaccine development platforms: bacterial vaccines, viral vaccines, conjugate vaccines, and E.coli expressed ...

Transmembrane glycoproteins of enveloped viruses are targets of neutralizing antibodies and essential vaccine antigens. mRNA-LNP technology allows in vivo expression of transmembrane glycoproteins, ...

Vaccine development for aquaculture species encompasses a diverse array of approaches designed to prevent bacterial, viral and parasitic diseases in farmed fish. Conventional strategies include ...

Funded by the Global Health EDCTP3 Joint Undertaking, a new €15.3 million project coordinated by Institut Pasteur brings together seven partners across four continents to advance clinical trials and ...

This article examines the history of respiratory virus vaccines, how modified mRNA (modRNA) technology may overcome the limitations of existing vaccines, and the development of universal vaccines for ...